| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-13 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-12 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.23 | 9e-12 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-11 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-11 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-10 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-10 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-10 |